Page last updated: 2024-08-26

melanotan-ii and triazoles

melanotan-ii has been researched along with triazoles in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumane, L; Dambrova, M; Kalvinsh, I; Liepinsh, E; Muceniece, R; Vilskersts, R; Wikberg, JE; Zvejniece, L1
Baldini, G; Cooney, KA; Molden, BM; Van Der Ploeg, LH; West, K1

Other Studies

2 other study(ies) available for melanotan-ii and triazoles

ArticleYear
Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:6

    Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Electron Spin Resonance Spectroscopy; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles

2007
Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
    Molecular endocrinology (Baltimore, Md.), 2015, Volume: 29, Issue:11

    Topics: Adenylate Kinase; Agouti-Related Protein; alpha-MSH; AMP-Activated Protein Kinases; Animals; Cell Line; Cyclic AMP; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Mice; Peptides; Peptides, Cyclic; Photobleaching; Protein Conformation; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles

2015